Quan Capital logo

Quan Capital

Asia, Shanghai, China, Shanghai

Description

Quan Capital is a healthcare focused venture capital firm.

Investor Profile

Quan Capital has made 24 investments, with 3 in the past 12 months and 21% as lead.

Stage Focus

  • Series A (42%)
  • Series B (38%)
  • Series C (13%)
  • Series D (4%)
  • Series Unknown (4%)

Country Focus

  • United States (71%)
  • China (13%)
  • United Kingdom (8%)
  • Hong Kong (4%)
  • Switzerland (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
  • Life Science
  • Biopharma
  • Therapeutics
  • Oncology
  • Clinical Trials
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quan Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 5
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
Wellington Management
North America, Massachusetts, United States, Boston
Co-Investments: 4
3H Health Investment
Asia, Hong Kong Island, Hong Kong, Cyberport
Co-Investments: 3
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 5
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 6
ArrowMark Partners
North America, Colorado, United States, Denver
Co-Investments: 3
Fairmount Funds Management
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 4
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 5
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 5

What are some of recent deals done by Quan Capital?

Windward Bio

Basel, Basel-Stadt, Switzerland

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

BiotechnologyLife ScienceMedical
Series AJan 10, 2025
Amount Raised: $200,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series ANov 18, 2024
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series CMay 7, 2024
Amount Raised: $200,000,000
Avenzo Therapeutics

San Diego, California, United States

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series AMar 26, 2024
Amount Raised: $150,000,000
Crescendo Biologics

Cambridge, Cambridgeshire, United Kingdom

Crescendo Biologics is engaged in the development of a proprietary drug portfolio based on their VH antibody fragment platform.

BiotechnologyHealth CareTherapeutics
Series UnknownJul 24, 2023
Amount Raised: $32,000,000
Adcentrx Therapeutics

San Diego, California, United States

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

BiotechnologyPharmaceutical
Series AApr 24, 2023
Amount Raised: $51,000,000
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series CApr 12, 2023
Amount Raised: $29,091,755
Zenas BioPharma

Waltham, Massachusetts, United States

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

BiopharmaHealth CarePharmaceutical
Series BNov 7, 2022
Amount Raised: $118,000,000
Walking Fish Therapeutics

San Francisco, California, United States

Walking Fish Therapeutics is developing a platform to harness B cells’ capability to activate the immune system.

BiotechnologyLife Science
Series ASep 13, 2021
Amount Raised: $50,000,000
Alebund Pharmaceuticals

Shanghai, Shanghai, China

Alebund Pharmaceuticals is a biopharmaceutical company dedicated to developing innovative therapies for the treatment of renal diseases.

BiotechnologyLife SciencePharmaceutical
Series BSep 13, 2021
Amount Raised: $54,500,000